A healthy cardiovascular system is essential to good health. That’s why at Abbott, we’re advancing the treatment of heart and vascular disease through breakthrough medical technologies that are less invasive, allowing people to restore their health and get on with their lives.

Abbott focuses on improving treatment options for people with coronary artery disease, mitral regurgitation and peripheral artery disease. We’re working on timely advances and innovative technologies that have the potential to improve the way doctors treat people with vascular diseases.




Abbott’s vascular manufacturing facility in Clonmel helps meet worldwide demand for vascular devices.

The original 150,000-square-foot facility was established on 55 acres by Digital Corp in 1980. Today, the modern 250,000-square-foot facility on a 19-acre site is a centre of excellence in the manufacturing of vascular devices.




Abbott’s vascular business in Clonmel manufactures a broad range of vascular devices, including stent delivery systems.

Key products include:

  • XIENCE Alpine & XIENCE Xpedition – drug-eluting stent delivery systems
  • ProGlide, StarClose and Prostar , – products to facilitate secure closure of vascular access sites
  • Armada 14 & Armada 18–peripheral dilatation catheters
  • Omnilink Elite – a peripheral stent delivery system
  • Graftmaster – a coronary stent graft system


Abbott Vascular, Clonmel
Cashel Road
Tel: +353 (0)52 617 3000